WHITEPAPER
13 Key Recommendations for Aspiring DiGA Manufacturers in 2026
Practical Experience from Our DiGA Projects
Last updated: January 2026
Contents
- Development, approval, study,
and sales of your DiGA
- Our experience from numerous DiGA projects
- Practical advice for aspiring DiGA manufacturers
- The key risks
for approval by the BfArM
In this whitepaper, we have summarized the experience from our successfully completed DiGA projects to pave the way for your official listing in the directory of the BfArM (Federal Institute for Drugs and Medical Devices). Our recommendations are intended not only to help you achieve a successful and regulatory-compliant entry into the healthcare market, but also to significantly accelerate this undertaking. That is because we answer important fundamental questions that every manufacturer should ask at the start of developing their DiGA in order to ensure the future success of the application.


